Cargando…

Global Longitudinal Strain or Measurement of Ejection Fraction: Which Method is Better in Stratifying Patients with Heart Failure?

Detalles Bibliográficos
Autores principales:	Ferrari, Filipe, Menegazzo, Willian Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2019
Materias:	Short Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777883/ https://www.ncbi.nlm.nih.gov/pubmed/31483015 http://dx.doi.org/10.5935/abc.20190151

Ejemplares similares

Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction
por: Tanacli, Radu, et al.
Publicado: (2020)

Global Longitudinal Strain or Left Ventricular Twist and Torsion? Which Correlates Best with Ejection Fraction?
por: Lima, Marcio Silva Miguel, et al.
Publicado: (2017)

The effect of exercise training on biventricular myocardial strain in heart failure with preserved ejection fraction
por: Angadi, Siddhartha S., et al.
Publicado: (2017)

A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction
por: Verdonschot, Job A.J., et al.
Publicado: (2021)

Predictive value of global longitudinal strain by left ventricular ejection fraction
por: Medvedofsky, Diego, et al.
Publicado: (2023)

Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
por: D'Assante, Roberta, et al.
Publicado: (2021)

High Intensity Exercises in Heart Failure with Preserved Ejection Fraction
por: Herdy, Artur Haddad, et al.
Publicado: (2018)

Left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: outcomes following an acute heart failure hospitalization
por: Buggey, Jonathan, et al.
Publicado: (2017)

Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction
por: Al‐Jarallah, Mohammed, et al.
Publicado: (2019)

Role of global longitudinal strain in assessment of left ventricular systolic function in patients with heart failure with preserved ejection fraction
por: Bshiebish, Hasanain Ali Hameed, et al.
Publicado: (2019)

Minimal subphenotyping model for acute heart failure with preserved ejection fraction
por: Sotomi, Yohei, et al.
Publicado: (2022)

Different Pathophysiology and Outcomes of Heart Failure With Preserved Ejection Fraction Stratified by K-Means Clustering
por: Harada, Daisuke, et al.
Publicado: (2020)

Distinctive prognostic factor of heart failure with preserved ejection fraction stratified with admission blood pressure
por: Nakagawa, Akito, et al.
Publicado: (2021)

Differential Response to Interleukin‐1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction
por: Golino, Michele, et al.
Publicado: (2023)

Phenotyping Heart Failure According to the Longitudinal Ejection Fraction Change: Myocardial Strain, Predictors, and Outcomes
por: Park, Jin Joo, et al.
Publicado: (2020)

Real‐world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
por: Oh, Jaewon, et al.
Publicado: (2022)

Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction
por: Erhardsson, Mikael, et al.
Publicado: (2023)

Additive Value of Biomarkers and Echocardiography to Stratify the Risk of Death in Heart Failure Patients with Reduced Ejection Fraction
por: Falletta, Calogero, et al.
Publicado: (2019)

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial
por: Scheffer, Mariëlle, et al.
Publicado: (2020)

Effects of homoarginine supplementation on heart and skeletal muscle of rats with heart failure with preserved ejection fraction
por: Büttner, Petra, et al.
Publicado: (2022)

The clinical significance of plasma neopterin in heart failure with preserved left ventricular ejection fraction
por: Yamamoto, Eiichiro, et al.
Publicado: (2015)

Recurrent heart failure with preserved ejection fraction associated with carfilzomib administration for multiple myeloma
por: Yang, Eric H., et al.
Publicado: (2018)

Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction
por: Tamaki, Shunsuke, et al.
Publicado: (2020)

Plasma P‐selectin is a predictor of mortality in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2021)

Development of heart failure with preserved ejection fraction is independent of eosinophils in a preclinical model
por: Pan, Qi, et al.
Publicado: (2023)

Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease
por: Lee, Seonhwa, et al.
Publicado: (2020)

Relative contribution of risk factors/co‐morbidities to heart failure pathogenesis: interaction with ejection fraction
por: Giamouzis, Grigorios, et al.
Publicado: (2020)

Sex‐specific bimodal clustering of left ventricular ejection fraction in patients with acute heart failure
por: Henneges, Carsten, et al.
Publicado: (2021)

Deep learning detects heart failure with preserved ejection fraction using a baseline electrocardiogram
por: Unterhuber, Matthias, et al.
Publicado: (2021)

Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes
por: Gevaert, Andreas B., et al.
Publicado: (2021)

Left ventricular global longitudinal strain is associated with exercise capacity in failing hearts with preserved and reduced ejection fraction
por: Hasselberg, Nina E., et al.
Publicado: (2015)

Global longitudinal strain, ejection fraction, effort tolerance and normal echocardiography measurements in healthy Indians
por: Sullere, Vivek, et al.
Publicado: (2018)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Prospective population studies of incident heart failure without data on baseline left ventricular ejection fraction
por: Mujib, Marjan, et al.
Publicado: (2010)

Sex differences in efficacy of pharmacological therapies in heart failure with reduced ejection fraction: a meta‐analysis
por: Danielson, Cecilia, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction
por: Brownell, Nicholas K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_03dfcktf1dhdbamm5oc8f8fcv5